Making Grove's mechanism of action visible

Grove Biopharma had a binding mechanism that looked simple on a slide and turned out to be the whole story. The molecule does its work in a sequence most people — including some in the room — had never actually seen. The science was sound. The problem was that it lived in static diagrams and a spec sheet, and neither could show the part that mattered: the moment of engagement.

The brief under the brief

The stated ask was a short explainer. The real ask, once we dug in, was to make a non-specialist feel the same certainty a Grove scientist feels when they look at the mechanism. That's a higher bar than "explain the product," and it changed every decision that followed.

What we built

We built the sequence as a 90-second reel: the protein, the target, the moment they engage, and what changes downstream. No labels the audience didn't need. No flourish that didn't serve the mechanism. The depth was chosen carefully — far enough in to be true, not so far that the viewer drowns in structure.

The three decisions that mattered

• Open on the problem the molecule solves, not the molecule. Context first, hero second.
• Hold on the engagement a beat longer than felt comfortable — it's the payoff, and audiences need a moment to register it.
• Stop. The downstream cascade is real and fascinating and entirely beside the point of this particular reel.

What changed

The reel became the opener for Grove's pitches. Sales stopped narrating a diagram and started letting the audience watch the mechanism work. The science was never dumbed down — every frame would survive scrutiny from the people who designed the molecule. It simply became something a room could see at once, instead of something a few people could read.

That's the work, on most projects: not making the science simpler, but making it visible. The clarity was there all along. We just gave it ninety seconds to move.